News

Healthline9mon
All About Enhertu
This section describes commonly used dosages of Enhertu, but your doctor will determine the dosage that is right for you. Enhertu comes as a powder in a single-dose vial. Each vial contains 100 ...
AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer
AstraZeneca (NASDAQ:AZN) is one of the 8 Best Inexpensive Stocks to Buy Right Now. On June 9, the first patient was dosed by ...
Morningstar1mon
ENHERTU® Followed by THP Before Surgery Showed Statistically Significant and Clinically Meaningful Improvement in Pathologic Complete Response in Patients With High-Risk HER2 ...
four cycles of ENHERTU followed by four cycles of THP; or four cycles of ddAC (dose-dense doxorubicin and cyclophosphamide) followed by four cycles of THP. The primary endpoint of DESTINY-Breast11 ...
Yahoo Finance1mon
ENHERTU® (fam-trastuzumab deruxtecan-nxki) followed by THP before surgery showed statistically significant and clinically meaningful improvement in pathologic complete ...
May 07, 2025--(BUSINESS WIRE)--Positive high-level results from the DESTINY-Breast11 Phase III trial showed ENHERTU ® (fam-trastuzumab ... rate versus standard of care (dose-dense doxorubicin ...
FiercePharma1mon
Fierce Pharma Asia—Enhertu's first-line win; Akeso bispecific's positive readout; Regeneron, Fujifilm's $3B deal
AstraZeneca, Daiichi say Enhertu delivers 'highly statistically ... Ascletis sees no benefit to high, fast oral GLP-1 dose titration, takes low, slow regimen forward Ascletis posted some baffling ...
Pharmabiz1mon
Enhertu followed by THP before surgery showed statistically significant and clinically meaningful improvement in pCR in patients with high-risk HER2-positive early-stage breast ...
four cycles of Enhertu followed by four cycles of THP; or four cycles of ddAC (dose-dense doxorubicin and cyclophosphamide) followed by four cycles of THP. The primary endpoint of DESTINY-Breast11 is ...